This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Harvard Bioscience Inc (HBIO)

NASDAQ: Health Care

Company Income Statement
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Sales 108.66M 105.17M 111.17M 108.86M
Cost of Sales 57.96M 56.03M 57.25M 56.93M
Gross Operating Profit 50.70M 49.14M 53.92M 51.93M
Selling, General, and Administrative Expenses 35.05M 35.22M 38.87M 35.54M
Research & Development 4.88M 4.15M 7.32M 5.43M
Operating Income before D & A (EBITDA) 10.77M 9.77M 7.73M 10.96M
Depreciation & Amortization 3.94M 4.04M 4.26M 4.42M
Interest Income 74.00K 43.00K 46.00K 65.00K
Other Income - Net -1.28M -2.24M -400.00K -848.00K
Special Income / Charges 810.00K 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) 5.41M 1.39M 2.81M 5.29M
Interest Expense 990.00K 955.00K 584.00K 752.00K
Pre-Tax Income 4.42M 435.00K 2.23M 4.54M
Income Taxes 2.06M -288.00K 696.00K 730.00K
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations 2.35M 723.00K 1.53M 3.81M
Net Income From Discontinued Operations 0.00 -2.55M 838.00K 0.00
Net Income From Total Operations 2.35M -1.83M 2.37M 3.81M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 2.35M -1.83M 2.37M 3.81M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
2.57M 2.87M 1.84M 4.28M
Preferred Dividends
Net Income Available To Common 2.35M 723.00K 1.53M 3.81M
Basic EPS from Continuing Ops. 0.07 0.02 0.05 0.13
Basic EPS from Discontinued Ops. 0.00 -0.08 0.03 0.00
Basic EPS from Total Operations 0.07 -0.06 0.08 0.13
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total 0.07 -0.06 0.08 0.13
Basic Normalized Net Income/Share 0.08 0.08 0.06 0.15
EPS fr Continuing Ops. 0.07 0.02 0.05 0.13
EPS fr Discontinued Ops 0.00 -0.08 0.03 0.00
EPS fr Total Ops. 0.07 -0.06 0.08 0.13
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total 0.07 -0.06 0.08 0.13
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
0.08 0.08 0.06 0.15
Dividends Paid per Share 0.00 0.00 0.00 0.00
HBIO News

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

HBIO Harvard Bioscience Inc

Chart of HBIO

Analysts Ratings for HBIO

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 1 1 1 1
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET HBIO ANALYST REPORT

HBIO Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs